Zolmitriptan

Suppliers

Names

[ Name ]:
Zolmitriptan

[Synonym ]:
2-Oxazolidinone, 4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-, (4S)-
BW 311C90
(S)-4-[[3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone
Zomigoro
(4S)-4-({3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one
Zolmitriptan
Zomigon
(4R)-4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one
(S)-N,N-Dimethyl-2-[5-(2-oxo-1,3-oxazolidin-4-ylmethyl)-1H-indol-3-yl]ethylamine
AscoTop
Zomig
MFCD00871503

Chemical & Physical Properties

[ Density]:
1.2±0.1 g/cm3

[ Boiling Point ]:
563.3±38.0 °C at 760 mmHg

[ Melting Point ]:
136-141ºC

[ Molecular Formula ]:
C₁₆H₂₁N₃O₂

[ Molecular Weight ]:
287.357

[ Flash Point ]:
294.5±26.8 °C

[ Exact Mass ]:
287.163391

[ PSA ]:
57.36000

[ LogP ]:
1.64

[ Vapour Pressure ]:
0.0±1.5 mmHg at 25°C

[ Index of Refraction ]:
1.620

[ Storage condition ]:
Refrigerator

MSDS

Click to get detail MSDS

Safety Information

[ Hazard Codes ]:
Xi: Irritant;

[ Risk Phrases ]:
R36/37/38

[ Safety Phrases ]:
S26-S36

[ RIDADR ]:
NONH for all modes of transport

[ RTECS ]:
RQ2707000

[ HS Code ]:
2934999090

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

Zolmitriptan-2-carboxylic Acid
(4,4-Dimethoxy-butyl)-dimethyl-amine
Formaldehyde
4-[[3-(2-aminoethyl)-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one
ZolMitriptan
ethyl 3-[2-(dimethylamino)ethyl]-5-[[(4S)-2-oxo-1,3-oxazolidin-4-yl]methyl]-1H-indole-2-carboxylate
(4,4-Diethoxy-butyl)-dimethyl-amine
(S)-4-(4-Aminobenzyl)oxazolidin-2-one

DownStream

Customs

[ HS Code ]: 2934999090

[ Summary ]:
2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Articles

Bioenhanced sublingual tablet of drug with limited permeability using novel surfactant binder and microencapsulated polysorbate: In vitro/in vivo evaluation.

Eur. J. Pharm. Biopharm. 94 , 386-92, (2015)

Formulation of sublingual tablets of drugs with limited permeability poses a great challenge due to their poor absorption. In this study, bioenhanced sublingual tablets (BESTs) of zolmitriptan were pr...

Zolmitriptan: a novel portal hypotensive agent which synergizes with propranolol in lowering portal pressure.

PLoS ONE 8(1) , e52683, (2013)

Only a limited proportion of patients needing pharmacological control of portal hypertension are hemodynamic responders to propranolol. Here we analyzed the effects of zolmitriptan on portal pressure ...

Preparation and evaluation of zolmitriptan submicron emulsion for rapid and effective nasal absorption in beagle dogs.

Drug Dev. Ind. Pharm. 37(12) , 1509-16, (2011)

Submicron emulsion was prepared for rapid and effective nasal absorption of zolmitriptan (ZT). The different charge inducers and pH values of the formulations were evaluated to optimize the formulatio...

ZolMitriptan
Zolmitriptan-d6
Zolmitriptan N-Oxide
Zolmitriptan R-Isomer
Zolmitriptan-d6 N-Oxide
Decarbonyl zolmitriptan
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
5-(1H-1,3-Benzodiazol-2-YL)pentan-2-OL
(2-Fluoro-4-((4-fluorophenyl)carbamoyl)phenyl)boronic acid
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
(4-Methyl-tetrahydro-furan-2-yl)-methanol
N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
3-Tert-butoxy-4-chloro-5-cyclopropoxypyridine
N-(3-ethylphenyl)-2-{[3-(3-methoxybenzyl)-4-oxo-7-phenyl-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidin-2-yl]sulfanyl}acetamide